Appendix B
Open Meeting Agendas
Meeting I
April 3 and 4, 2000
The Foundry Building, Washington, D.C.
3 April 2000
10:00AM |
Sponsor Presentation: Charge to the IOM and Welcoming Remarks MG John S. Parker, M.D., Commanding General U.S. Army Medical Research and Materiel Command |
|
Overview of the Military Infectious Diseases Research Program COL Charles H. Hoke, Jr., M.D., Research Area Director Military Infectious Diseases Research Program |
11:00AM |
Break |
11:15AM |
Sponsor Presentation, continued Overview of the DoD Research and Development (Acquisition) Model COL Rodney A. Michael, M.D. Research Area Deputy Director Military Infectious Diseases Research Program |
|
Biologic Warfare Defense Research and Endemic Infectious Diseases Research: Whence and why the dichotomy COL John F. Glenn, Ph.D. Deputy for Research and Development U.S. Army Medical Research and Materiel Command |
12:15PM |
Lunch |
1:15PM |
Discussion with Sponsor: Current challenges Overview of the challenges to adequate vaccine strategy presented by industry and DoD policies and constraints Overview of the regulatory parameters that currently affect military vaccine strategy Discussion of what the U.S. Army seeks to gain from this committee report Discussion of charge |
2:15PM |
Break, end of open session |
Meeting II
June 19 and 20, 2000
The Foundry Building, Washington, D.C.
19 June 2000
10:00AM |
Welcome and Introduction Stanley Lemon, M.D., Chair |
10:05AM |
Examples of the Impact of Vaccine Preventable Infectious Disease: |
|
Impact of Recent Adenovirus Outbreaks in Military Training Centers CAPT Gregory Gray, M.D., M.P.H. Director, DoD Center for Deployment Health Research Naval Health Research Center, San Diego |
|
Lt Col James Neville, M.D., M.P.H. Chief, Force Health Protection and Surveillance Branch U.S. Air Force Institute for Environment, Safety & Occupational Health Risk Analysis Brooks Air Force Base |
|
Leonard N. Binn, Ph.D. Supervisory Research Microbiologist, Department of Virus Diseases Walter Reed Army Institute of Research |
|
The Meningococcal Meningitis Situation, Military and Civilian Juliette Morgan, M.D. Medical Epidemiologist, Meningitis and Special Pathogens Branch Centers for Disease Control and Prevention |
|
John Brundage, M.D., M.P.H. Senior Research Epidemiologist, Henry M. Jackson Foundation Army Medical Surveillance Activity Walter Reed Army Institute of Research |
11:30AM |
JVAP—Procurement Process for Vaccines for Biowarfare Defense Richard B. Paul, M.A. Acting Program Manager, Joint Vaccine Acquisition Program |
12:00PM |
Vaccine Development Success–Policy Failure Adenovirus Vaccine: Successful Development Franklin H. Top, Jr., M.D. Executive Vice President and Medical Director, MedImmune |
|
Adenovirus Vaccine: A Policy Failure Joel Gaydos, M.D., M.P.H. DoD Global Emerging Infections Surveillance & Response System, Division of Preventive Medicine, Walter Reed Army Institute of Research |
12:45PM |
Lunch (and continued discussion) |
1:30PM |
Vaccine Research & Development: Priority Setting DoD Requirements Generation and Acquisition James H. Nelson, Ph.D. Director, U.S. Army Medical Materiel Development Activity |
|
Military Medical Surveillance of Infectious Disease LTC Mark V. Rubertone, M.D., M.P.H. Chief, Army Medical Surveillance Activity U.S. Army Center for Health Promotion and Preventive Medicine |
|
Medical Intelligence Deborah G. Keimig, Ph.D. Chief, Epidemiology and Environmental Health Division Armed Forces Medical Intelligence Center, Fort Detrick |
|
Priority Setting in Practice COL Rodney A. Michael, M.D. Deputy Director, Military Infectious Disease Research Program |
|
Discussion |
4:00PM |
Open session ends |
20 June 2000
7:30AM |
Continental Breakfast |
8:00AM |
Review of Meeting Day 1 and Introduction of Day 2 Program Stanley Lemon, M.D., Chair |
8:20AM |
Status of Limited Use Vaccines in the Military LTC Phillip R. Pittman, M.D., M.P.H. Senior Medical Scientist U.S. Army Research Institute of Infectious Diseases |
8:50AM |
How Others (Try to) Make Limited Use Vaccine Development Work: |
|
Food and Drug Administration Karen Goldenthal, M.D. Director, Division of Vaccines & Related Products Applications |
|
National Institute of Allergy and Infectious Disease, National Institutes of Health Carole A. Heilman, Ph.D. Director, Division of Microbiology and Infectious Diseases |
|
Centers for Disease Control and Prevention James W. LeDuc, Ph.D. Acting Director, Division of Viral and Rickettsial Diseases National Center for Infectious Diseases Centers for Disease Control and Prevention |
|
Industry Involvement in Federal Vaccine Development and Procurement Efforts Thomas P. Monath, M.D. Vice President, Research & Medical Affairs, OraVax Inc. |
|
Discussion: Constraints Faced and Handled How Might DoD Use These Approaches |
11:45AM |
Lunch—with concurrent discussion based on morning’s presentations Open session ends |
Meeting III
September 21 and 22, 2000
The Foundry Building, Washington, D.C.
21 September 2000
11:00AM |
Welcome Stanley Lemon, M.D., Chair |
11:05AM |
Adenovirus vaccine MAJ Michael Dyer, M.S. Office of the TRADOC Surgeon William Howell Deputy for Acquisition and Advanced Development U.S. Army Medical Research and Materiel Command |
12:00PM |
Lunch |
12:45PM |
Vaccine production Gary Nabel, M.D., Ph.D. Director, NIH Vaccine Research Center Jack Melling, Ph.D. formerly with the Salk Institute and the Center for Applied Microbiology and Research |
2:00PM |
Priorities LTC Brian G. Scott, M.D. Clinical Consultant, Force Protection AMEDD Center and School Directorate of Combat and Doctrine Development |
|
COL John Frazier Glenn, Ph.D. Deputy for Research and Development U.S. Army Medical Research and Materiel Command |
|
Discussion Presenters along with: COL Charles Hoke, Jr., M.D. COL Rodney Michael, M.D. |
4:00PM |
Discussion |
5:00PM |
Adjourn for the day |
Meeting IV
November 13 and 14, 2000
The Foundry Building, Washington, D.C.
13 November 2000
9:30AM |
Continental breakfast in conference room |
10:00AM |
Review agenda, introduce speakers |
10:10AM |
Incentivizing limited use vaccine production: getting and keeping vaccines Kevin L. Reilly President, Wyeth Vaccines, Wyeth Pharmaceuticals |
11:30AM |
Public release of this committee’s interim report: Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine Availability: A Letter Report Stanley Lemon, M.D., Chair |
|
Adenovirus update CDR Jeff Yund, M.D. Division of Preventive Medicine and Occupational Health U.S. Navy Bureau of Medicine and Surgery |
12:30PM |
Working lunch in conference room for committee, staff, and guests |
1:30PM |
Priority setting revisited (panel discussion) COL John Frazier Glenn, Ph.D. Deputy for Research and Development U.S. Army Medical Research and Materiel Command |
|
LTC Brian G. Scott, M.D. Clinical Consultant, Force Protection Directorate of Combat and Doctrine Development AMEDD Center & School |
|
COL Charles Hoke, Jr., M.D. Director, Military Infectious Diseases Research Program U.S. Army Medical Research and Materiel Command |
3:00PM |
Open session ends |
Meeting V
Tuesday, February 27, 2001
The Foundry Building, Washington, D.C.
12:00PM |
Working lunch in conference room for committee, staff, and guests |
1:00PM |
Setting vaccine priorities in DoD Anna Johnson-Winegar, Ph.D. Deputy Assistant to the Secretary of Defense Counterproliferation and Chemical/Biological Defense |
2:00PM |
Open session ends |